PROVIDER PROFILE · NPI 1508891623

Thomas Fitzharris

Internal MedicineDallas, TXI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

290

Beneficiaries

—

Total drug cost

$3K

Distinct drugs

Brand share

4.5%

Top prescribed drugs

Atorvastatin Calcium40 claims

Metoprolol Succinate35 claims

Amlodipine Besylate29 claims

Simvastatin21 claims

Levothyroxine Sodium20 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$279

Payment records

By payment type

Food and Beverage$279

REFERRAL NETWORK

Where Thomas Fitzharris's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 12 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS	91	278
David Zorinsky Diagnostic Radiology · Dallas, TX	33	53
Swdic Imaging Center Partnership, Llp Independent Diagnostic Testing Facility (IDTF) · Dallas, TX	28	64
REDISH, GREGORY	23	78
Honling Yuen Internal Medicine · Dallas, TX	22	54
NPI 1124082920	18	25
Robert Rinkenberger Cardiology · Plano, TX	16	95
BAYLOR UNIVERSITY MEDICAL CENTER	15	31
Medford Mccoy Pathology · Dallas, TX	14	39
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	14	39
Alfred Holden Urology · Dallas, TX	13	41
MILLER, RUDOLPH	12	21

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history